LAWSUITS NEWS & LEGAL INFORMATION
Talcum Powder Legal News Articles & Interviews
Victory for Women with Ovarian Cancer linked to Johnson & Johnson’s Talc in Missouri Court of Appeals

Asbestos Re-Surfaces in J&J Talcum Powder

J&J Wins a Few Asbestos Talc Trials--and Loses More

Johnson and Johnson Asbestos Talc Trials Not About Attorneys

J&J Presents Article in Asbestos Talc Trial Indicating Weak Link to Peritoneal Mesothelioma

Johnson & Johnson Investors Accuse the Company of Cover-Up

J&J argues that its shareholders are attempting to rehash decades-old allegations, but the proposed class said that the company failed to actually respond to most of the alleged misstatements in that filing. According to Law360, “The [complaint] sets forth each alleged misrepresentation and omission, which of the defendants made each statement, the date of each statement and the reasons each statement was false and misleading,” the investors said. “Nothing more is required. Notably, defendants fail to challenge many of the misstatements, conceding their falsity.”
Shareholder Frank Hall filed the putative class action in New Jersey federal court claiming that J&J harmed its stockholders by concealing the truth underlying lawsuits and articles contending that J&J’s talcum powder products contain asbestos. According to the complaint, J&J knew for decades that its talc products, namely Johnson’s Baby Powder, contain asbestos fibers and that exposure to J&J’s talc can cause mesothelioma and ovarian cancer. Also, J&J’s revenues from sales of these products were unsustainable due to the dangerous and harmful nature of its talc products. And In the 1990s, J&J outlined a plan to hike flagging sales of its powder “by targeting” black and Hispanic women, according to a company memorandum made public in recent lawsuits against J&J.
Further, by not disclosing this danger, J&J kept its stock price artificially high and harmed shareholders who saw prices drop by more than 5 percent when the media reported the information. The lawsuit cites falls in shares that damaged investors from the following news:
1. On September 21, 2017, Bloomberg published an article titled, “Johnson &Johnson alerted to risk of asbestos in talc in '70s, files show,” stating “documents indicate that J&J has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer.” Shares of J&J fell $2.28 per share over five consecutive trading days to close at $129.47 per share on September 28, 2017.
2. On February 5, 2018, CNBC published an article titled, “Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents. Shares of J&J fell $7.29 per share or over 5% from its previous closing price to close at $130.39 per share on February 5, 2018,
3. On February 7, 2018, during aftermarket hours, the Beasley Allen Law Firm issued a press release stating that “[l]awsuits filed by ovarian cancer and mesothelioma victims are revealing never-before-seen documents from Johnson & Johnson and talc supplier, Imerys, that shed light on just how prevalent asbestos and heavy metals are in the talc used in Baby Powder.” The release stated that “[i]nternal Johnson & Johnson documents from 1972 note that asbestos was found in 100 percent of talc samples tested at the time, but this information was never released publicly.” It further stated that J&J stopped funding a project designed to test talc samples for asbestos contamination once a majority of the sample batches were found to be
positive for asbestos.”
This is a
Another Victory for J&J Talc Lawsuit Plaintiff

Asbestos Mesothelioma and Ovarian Cancer Victims Claim they Breathed J&J Talc Dust

$29 Million Verdict in Talcum Powder Lawsuit

Subpoenas Fly! Senate Demands Docs in Tainted Talcum Powder Probe

- Imerys Talc Claims Bankruptcy, J&J Ovarian Cancer Claims Continue By Jane Mundy (Feb-18-19)
- Tests and Studies For and Against J&J Talc - Jury Still Out By Jane Mundy (Jan-22-19)
- New Jersey Win for Johnson & Johnson and Los Angeles Mistrials in Asbestos –Mesothelioma Cancer Talc Trials By Jane Mundy (Oct-17-18)
- Talcum Cancer Lawsuit in California Based on Trust By Jane Mundy (Sep-10-18)
- J&J’s Talc Appeal – Lack of Scientific Evidence and Jurisdiction Argument By Jane Mundy (Jul-30-18)
- “The Public Must Pressure Johnson & Johnson to List all their Talcum Powder Ingredients", says Attorney By Jane Mundy (Mar-31-18)
- The Talcum Powder Cases Heading for Massive Trials Next Year By Brenda Craig (Dec-12-17)
- Johnson & Johnson Wins First Mesothelioma Trial By Anne Wallace (Nov-28-17)
- Talcum Powder Judgements for Plaintiffs Reversed, Casting Similar Cases into Doubt By Jane Mundy (Nov-12-17)
- Rumors of Doom for Talcum Powder Lawsuits Greatly Exaggerated By Anne Wallace (Oct-29-17)
- Mesothelioma and Ovarian Cancer Talc Lawsuits Have in Common the Talc Supplier By Jane Mundy (Oct-14-17)
- J&J Seeks Judgment Notwithstanding the Verdict in Talcum Powder Lawsuit By Anne Wallace (Sep-30-17)
- Talcum Powder Trials: Sympathy versus Science? By Jane Mundy (Sep-19-17)
- New Information Shown to Jury Produced Record Talc Verdict By Brenda Craig (Aug-30-17)
- Still Too Soon to Take Echeverria to the Bank By Anne Wallace (Aug-26-17)
- Talcum Powder Cancer Trial: Who is More Credible? By Jane Mundy (Aug-20-17)
- Toxic Talc Trial Begins in California By Jane Mundy (Jul-29-17)
- Supreme Court Ruling May Affect Talcum Powder Lawsuit Claims By Deb Hipp (Jul-13-17)
- Talcum Powder Cancer Trial Not Boding Well for Johnson & Johnson By Jane Mundy (Jun-20-17)
- More Johnson & Johnson Talcum Powder Lawsuits Transferred to New Jersey MDL By Deb Hipp (Jun-5-17)
- Talcum Powder Timeframe: From Scientific Studies to Safety Concerns to Lawsuits By Jane Mundy (May-23-17)
- $110 Million Talc Verdict Comes Down in Favor of Plaintiff By Brenda Craig (May-10-17)
- $110M Verdict Against J&J In Talc Cancer Trial By Lucy Campbell (May-5-17)
- Round 5: Talcum Powder Plaintiffs versus Johnson & Johnson By Jane Mundy (May-1-17)
- Missouri Talcum Powder Cancer Lawsuit Could Go to New Jersey MDL By Deb Hipp (Apr-11-17)
- Missouri Jury in Talcum Powder Lawsuit sides with J&J By Jane Mundy (Mar-22-17)
- Missouri Jury Finds in Favor of Johnson & Johnson on Talcum Powder Case By Deb Hipp (Mar-10-17)
- Talcum Powder Ovarian Cancer Whistleblower By Jane Mundy (Feb-21-17)
- New Talcum Powder Cancer Lawsuit Against Johnson & Johnson Filed By Multiple Plaintiffs By Deb Hipp (Feb-9-17)
- J&J Talcum Powder Lawsuit Claims Ovarian Cancer Risk Was Known By Lucy Campbell (Feb-3-17)
- Johnson & Johnson Loses Bid to Delay Talcum Powder Cancer Trials By Heidi Turner (Jan-23-17)
- More Talc Litigation Coming in 2017 By Brenda Craig (Jan-19-17)
- J&J’s Cost of Defending its Talcum Powder is Rising By Jane Mundy (Jan-6-17)
- Wrongful Death Talcum Powder Lawsuit Filed By Heidi Turner (Dec-23-16)
- Talcum Powder Cancer Concerns By Jane Mundy (Dec-3-16)
- More Talcum Powder Lawsuits Filed as Woman Awarded $70 Million By Heidi Turner (Nov-26-16)
- Mothers and Grandmother Passed yet Talcum Powder Remains By Jane Mundy (Nov-7-16)
- Woman Awarded $70 Million in Talcum Powder Lawsuit By Heidi Turner (Oct-28-16)
- Many Talcum Powder Lawsuit Plaintiffs May Not Survive to See Their Day in By Gordon Gibb (Oct-5-16)
- J&J Talcum Powder Case Will Be Heard in Court By Lucy Campbell (Sep-26-16)